or
forgot password

    • cancer clinical trials in charleston, SC

    • Spy II Clinical Registry
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Biliary Tract Diseases
    Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
    Medical University Of SC CAR
    Charleston, South Carolina 29425
    Crohn's Disease
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
    Medical University Of SC CAR
    Charleston, South Carolina 29425
    Ulcerative Colitis
    Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Leukemia
    Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents
    Charleston Hematology Oncology, PA
    Charleston, South Carolina 29403
    Fatigue, Chemotherapy Side Effects
    Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer
    Research Site
    Charleston, South Carolina
    Cancer, Carcinoma, Castrate-Resistant Prostate Cancer, Prostate Cancer, Tumors
    PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening
    Medical University of South Carolina Digestive Disease Center
    Charleston, South Carolina 29425
    Colorectal Cancer
    Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Brain Diseases, Spinal Cord Diseases
    ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension
    Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Breast Cancer
    S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma
    Charleston Hematology Oncology, PA
    Charleston, South Carolina 29403
    Multiple Myeloma
    Study of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer
    Investigative Site
    Charleston, South Carolina
    Chemotherapy Induced Anemia
    Study Comparing EBUS & EUS to Mediastinoscopy in Staging and Detection of Lung Cancer
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Non Small Cell Lung Cancer
    Efficacy and Safety of Ultratrace™ Iobenguane I 131 in Neuroblastoma
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Neuroblastoma
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Graft-versus-Host Disease, Immune System Disorders
    To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS.
    Charleston Hematology Oncology Associates
    Charleston, South Carolina 29403
    Myelodysplastic Syndromes
    S0916, MLN1202 in Treating Patients With Bone Metastases
    Hollings Cancer Center at Medical University of South Carolina
    Charleston, South Carolina 29425
    Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)
    Research Site
    Charleston, South Carolina
    Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
    A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Acute Myeloid Leukemia
    Surgical Versus Non-surgical Staging of Lung Cancer
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Lung Cancer
    A Study of Trastuzumab-MCC-DM1 in Patients With HER2- Positive Locally Advanced or Metastatic Breast Cancer
    Investigational Site
    Charleston, South Carolina 29414
    Metastatic Breast Cancer
    Trial of Intracycle Sequential Ofatumumab and Lenalidomide for the Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Chronic Lymphocytic Leukemia
    Study of Safety and Efficacy of OncoVEXGM-CSF With Cisplatin for Treatment of Locally Advanced Head and Neck Cancer
    Medical Univesity of South Carolina
    Charleston, South Carolina 29425
    SQUAMOUS CELL CARCINOMA, Head and Neck Cancer
    Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 kg
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Non-Hodgkin's Lymphoma
    A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
    Medical Research South, LLC

    Trial Locations
    Medical Research South, LLC
    Dermatology & Laser Center of Charleston
    Office of Marta T. Hampton, MD
    Psoriasis
    A Treatment-Option Study of Brentuximab Vedotin in Patients With Progression of Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma

    Charleston, South Carolina
    Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin
    GAMMA - Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
    Research Site
    Charleston, South Carolina
    Adenocarcinoma of the Pancreas, Advanced Solid Tumors, Cancer, Cancer of Pancreas, Cancer of the Pancreas, Metastases, Metastatic Cancer, Metastatic Pancreatic Cancer, Pancreas Cancer, Pancreatic Cancer, Bone Metastases, Endocrine Cancer, Oncology, Oncology Patients, Solid Tumors, Advanced Malignancy
    A Study of RO5185426 in Patients With Metastatic Melanoma

    Charleston, South Carolina
    Malignant Melanoma
    First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC

    Charleston, South Carolina
    Bladder Cancer
    Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Prostate Cancer, Prostatic Neoplasms
    An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
    Charleston Cancer Center

    Trial Locations
    Charleston Cancer Center
    Charleston Hematology Oncology Associates
    Chemotherapy-Induced Nausea and Vomiting
    VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis
    Nycomed Investigational Site
    Charleston, South Carolina
    Rheumatoid Arthritis
    Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Chemotherapy-Induced Nausea and Vomiting
    A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Discoid Lupus
    A Window of Opportunity Trial of Afatinib In Early Stage Non-Small Cell Lung Cancer (NSCLC)
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Lung Cancer
    Efficacy Of Copper To Reduce Acquisition Of Microbes and Healthcare-acquired Infections
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Healthcare-acquired Infection
    Expanded Access Program of Ponatinib
    Medical University of South Carolina, Site #148
    Charleston, South Carolina 29425
    Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
    Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Proteogenomic Monitoring in Liver Transplant Recipients
    Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT
    Medical University of South Carolina
    Charleston, South Carolina 29425-0721
    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)
    Phase 1 Study of PLX7486 as Single Agent and With Gemcitabine Plus Nab-Paclitaxel in Patients With Advanced Solid Tumors
    Medical Universtiy of South Carolina (MUSC)
    Charleston, South Carolina 29425
    Solid Tumors, Untreated Pancreatic Adenocarcinoma, Pancreatic Cancer Non-resectable, Metastatic Pancreatic Adenocarcinoma
    Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia
    Medical University of South Carolina MUSC
    Charleston, South Carolina 29425
    Acute Leukemias